imdx: the income statement

MyFinsight

Insight Molecular Diagnostics Inc. (IMDX)

For the quarter ending 2025-06-30, IMDX made $518K in revenue. -$9,742K in net income. Net profit margin of -1880.69%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Net revenue	518
Cost of revenues	168
Cost of revenues amortization of acquired intangibles	-
Gross profit	350
Sales and marketing	1,460
Research and development	3,281
General and administrative	2,647
Impairment loss on held for sale assets	-
Change in fair value of contingent consideration	2,804
Total operating expenses	10,192
Loss from operations	-9,842
Other income, net	125
Interest expense	-25
Total other income, net	100
Loss before income taxes	-9,742
Income taxes	-
Net loss	-9,742

Net loss attributable to common stockholders per share - basic	-0.3
Net loss attributable to common stockholders per share - diluted	-0.3
Weighted average shares outstanding - basic	32,023,000
Weighted average shares outstanding - diluted	32,023,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS)